183 related articles for article (PubMed ID: 31397069)
21. Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
Woo SY; Kie JH; Ryu KH; Moon HS; Chung WS; Hwang DH; Kim SK; Han TH; Hahn MJ; Chong YH; Park HK; Seoh JY
Scand J Immunol; 2002 Jan; 55(1):88-95. PubMed ID: 11841696
[TBL] [Abstract][Full Text] [Related]
22. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
Broudy VC; Lin NL; Kaushansky K
Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
[TBL] [Abstract][Full Text] [Related]
23.
Chen X; Wang C; Sun N; Pan S; Li R; Li X; Zhao J; Tong H; Tang Y; Han J; Qiao J; Qiu H; Wang H; Yang J; Ikezoe T
Theranostics; 2021; 11(10):4655-4671. PubMed ID: 33754019
[No Abstract] [Full Text] [Related]
24. [Nle4, D-Phe7]-α-MSH Inhibits Toll-Like Receptor (TLR)2- and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype.
Carniglia L; Ramírez D; Durand D; Saba J; Caruso C; Lasaga M
PLoS One; 2016; 11(6):e0158564. PubMed ID: 27359332
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin-independent effect of interferon-gamma on the proliferation of human megakaryocyte progenitors.
Muraoka K; Tsuji K; Yoshida M; Ebihara Y; Yamada K; Sui X; Tanaka R; Nakahata T
Br J Haematol; 1997 Aug; 98(2):265-73. PubMed ID: 9266918
[TBL] [Abstract][Full Text] [Related]
26. Chemokine production by human megakaryocytes derived from CD34-positive cord blood cells.
Takeuchi K; Higuchi T; Yamashita T; Koike K
Cytokine; 1999 Jun; 11(6):424-34. PubMed ID: 10346982
[TBL] [Abstract][Full Text] [Related]
27. [hNUDC promotes proliferation and differentiation of megakaryocytopoiesis on human CD341+ cells].
Chen YQ; Ge YC; Xu PL; Yang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):962-5. PubMed ID: 18845079
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes.
Schattner M; Lefebvre P; Mingolelli SS; Goolsby CL; Rademaker A; White JG; Foster D; Green D; Cohen I
Stem Cells; 1996 Mar; 14(2):207-14. PubMed ID: 8991540
[TBL] [Abstract][Full Text] [Related]
29. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
30. Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage.
D'Atri LP; Etulain J; Rivadeneyra L; Lapponi MJ; Centurion M; Cheng K; Yin H; Schattner M
J Thromb Haemost; 2015 May; 13(5):839-50. PubMed ID: 25594115
[TBL] [Abstract][Full Text] [Related]
31. Role of human interleukin-9 as a megakaryocyte potentiator in culture.
Fujiki H; Kimura T; Minamiguchi H; Harada S; Wang J; Nakao M; Yokota S; Urata Y; Ueda Y; Yamagishi H; Sonoda Y
Exp Hematol; 2002 Dec; 30(12):1373-80. PubMed ID: 12482498
[TBL] [Abstract][Full Text] [Related]
32. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
33. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
[TBL] [Abstract][Full Text] [Related]
34. Functional consequences of CD36 downregulation by TLR signals.
Zamora C; Cantó E; Nieto JC; Angels Ortiz M; Juarez C; Vidal S
Cytokine; 2012 Oct; 60(1):257-65. PubMed ID: 22795952
[TBL] [Abstract][Full Text] [Related]
35. [Influence of cytokine combinations on proliferation and differentiation of umbilical cord blood CD34(+) cells into megakaryocytes/platelets in vitro].
Zhang KY; Liu J; Jia YJ; Li W; Duan L; Gao SM; Cui S; Gong ZY; Ni L; Zhang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1053-7. PubMed ID: 21867643
[TBL] [Abstract][Full Text] [Related]
36. Producing megakaryocytes from a human peripheral blood source.
Ivetic N; Nazi I; Karim N; Clare R; Smith JW; Moore JC; Hope KJ; Kelton JG; Arnold DM
Transfusion; 2016 May; 56(5):1066-74. PubMed ID: 26756864
[TBL] [Abstract][Full Text] [Related]
37. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells.
Geisel J; Kahl F; Müller M; Wagner H; Kirschning CJ; Autenrieth IB; Frick JS
J Immunol; 2007 Nov; 179(9):5811-8. PubMed ID: 17947654
[TBL] [Abstract][Full Text] [Related]
38. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
40. Bupivacaine inhibits the TLR4- and TLR2-Myd88/NF-κB pathways in human leukocytes.
Binczak M; Purenne E; Beloeil H; Benhamou D; Mazoit JX
Fundam Clin Pharmacol; 2023 Apr; 37(2):347-358. PubMed ID: 36191347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
